New Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
New Capital Management's ABBV Position: Q3 2026 in Review
New Capital Management reduced its AbbVie (ABBV) stake by 0.28% in Q3 2026, selling an estimated $2.31K and leaving 3,254 shares worth $851K. The position accounts for 0.19% of the portfolio, ranked #37.
New Capital Management first reported a position in ABBV in Q4 2016 and has held it in 23 quarters since. 4,280 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- New Capital Management held 3,254 shares of AbbVie worth $851K as of Q3 2026.
- New Capital Management sold 9 AbbVie shares in Q3 2026, an estimated $2.31K.
- AbbVie made up 0.19% of New Capital Management's portfolio in Q3 2026, its #37 holding.
- New Capital Management first reported a position in AbbVie in Q4 2016 and has held it in 23 quarters since.
- 4,280 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on New Capital Management's 13F filing for Q3 2026, filed 29 Oct 2026.